Jiang S, Zhu D, Wang Y
Cancer Cell Int. 2025; 25(1):68.
PMID: 40011889
PMC: 11866835.
DOI: 10.1186/s12935-025-03668-3.
Song S, Wang C, Chen Y, Zhou X, Han Y, Zhang H
Cancer Immunol Immunother. 2025; 74(3):92.
PMID: 39891668
PMC: 11787113.
DOI: 10.1007/s00262-024-03936-7.
Krasik S, Bryushkova E, Sharonov G, Myalik D, Shurganova E, Komarov D
Elife. 2025; 13.
PMID: 39831798
PMC: 11745494.
DOI: 10.7554/eLife.89506.
Schlegel B, Morikone M, Mu F, Tang W, Kohanbash G, Rajasundaram D
NAR Genom Bioinform. 2024; 6(4):lqae137.
PMID: 39411512
PMC: 11474772.
DOI: 10.1093/nargab/lqae137.
Yu X, Song L, Cen L, Cao B, Tao R, Shen Y
Cell Rep Med. 2024; 5(10):101764.
PMID: 39368482
PMC: 11513832.
DOI: 10.1016/j.xcrm.2024.101764.
Chikungunya-Driven Gene Expression Linked to Osteoclast Survival and Chronic Arthralgia.
Urbanski A, Maso V, Martins F, da Costa-Martins A, do Nascimento Oliveira A, Nakaya H
Infect Dis Rep. 2024; 16(5):914-922.
PMID: 39311214
PMC: 11417755.
DOI: 10.3390/idr16050073.
Age-associated clonal B cells drive B cell lymphoma in mice.
Castro J, Shindyapina A, Barbieri A, Ying K, Strelkova O, Paulo J
Nat Aging. 2024; 4(10):1403-1417.
PMID: 39117982
DOI: 10.1038/s43587-024-00671-7.
A pan-cancer gamma delta T cell repertoire.
Yu X, Song L, Cen L, Cao B, Tao R, Shen Y
bioRxiv. 2024; .
PMID: 39091790
PMC: 11291071.
DOI: 10.1101/2024.07.18.604205.
Affinity gaps among B cells in germinal centers drive the selection of MPER precursors.
Ray R, Schiffner T, Wang X, Yan Y, Rantalainen K, Lee C
Nat Immunol. 2024; 25(6):1083-1096.
PMID: 38816616
PMC: 11147770.
DOI: 10.1038/s41590-024-01844-7.
A 10-Gene Signature to Predict the Prognosis of Early-Stage Triple-Negative Breast Cancer.
Kim C, Park K, Yu Y, Kim J, Park J, Park K
Cancer Res Treat. 2024; 56(4):1113-1125.
PMID: 38754473
PMC: 11491257.
DOI: 10.4143/crt.2024.100.
Premature skewing of T cell receptor clonality and delayed memory expansion in HIV-exposed infants.
Dzanibe S, Wilk A, Canny S, Ranganath T, Alinde B, Rubelt F
Nat Commun. 2024; 15(1):4080.
PMID: 38744812
PMC: 11093981.
DOI: 10.1038/s41467-024-47955-5.
Motive and opportunity: MYC rearrangements in high-grade B-cell lymphoma with MYC and BCL2 rearrangements (an LLMPP study).
Hilton L, Collinge B, Ben-Neriah S, Alduaij W, Shaalan H, Weng A
Blood. 2024; 144(5):525-540.
PMID: 38701426
PMC: 11307266.
DOI: 10.1182/blood.2024024251.
The potential and promise for clinical application of adoptive T cell therapy in cancer.
Li Y, Zheng Y, Liu T, Liao C, Shen G, He Z
J Transl Med. 2024; 22(1):413.
PMID: 38693513
PMC: 11064426.
DOI: 10.1186/s12967-024-05206-7.
Unified cross-modality integration and analysis of T cell receptors and T cell transcriptomes by low-resource-aware representation learning.
Gao Y, Dong K, Gao Y, Jin X, Yang J, Yan G
Cell Genom. 2024; 4(5):100553.
PMID: 38688285
PMC: 11099349.
DOI: 10.1016/j.xgen.2024.100553.
Molecular patterns of resistance to immune checkpoint blockade in melanoma.
Lauss M, Phung B, Holz Borch T, Harbst K, Kaminska K, Ebbesson A
Nat Commun. 2024; 15(1):3075.
PMID: 38594286
PMC: 11004175.
DOI: 10.1038/s41467-024-47425-y.
Low-dose dengue virus 3 human challenge model: a phase 1 open-label study.
Waickman A, Newell K, Lu J, Fang H, Waldran M, Gebo C
Nat Microbiol. 2024; 9(5):1356-1367.
PMID: 38561497
DOI: 10.1038/s41564-024-01668-z.
Multi-dimensional characterization of apoptosis in the tumor microenvironment and therapeutic relevance in melanoma.
Ye J, Wei B, Zhou G, Xu Y, He Y, Hu X
Cell Oncol (Dordr). 2024; 47(4):1333-1353.
PMID: 38502270
PMC: 11322377.
DOI: 10.1007/s13402-024-00930-0.
Genetic fusion of CCL11 to antigens enhances antigenicity in nucleic acid vaccines and eradicates tumor mass through optimizing T-cell response.
Qi H, Sun Z, Gao T, Yao Y, Wang Y, Li W
Mol Cancer. 2024; 23(1):46.
PMID: 38459592
PMC: 10921619.
DOI: 10.1186/s12943-024-01958-4.
Multi-omic profiling of follicular lymphoma reveals changes in tissue architecture and enhanced stromal remodeling in high-risk patients.
Radtke A, Postovalova E, Varlamova A, Bagaev A, Sorokina M, Kudryashova O
Cancer Cell. 2024; 42(3):444-463.e10.
PMID: 38428410
PMC: 10966827.
DOI: 10.1016/j.ccell.2024.02.001.
Murine MHC-Deficient Nonobese Diabetic Mice Carrying Human HLA-DQ8 Develop Severe Myocarditis and Myositis in Response to Anti-PD-1 Immune Checkpoint Inhibitor Cancer Therapy.
Racine J, Bachman J, Zhang J, Misherghi A, Khadour R, Kaisar S
J Immunol. 2024; 212(8):1287-1306.
PMID: 38426910
PMC: 10984778.
DOI: 10.4049/jimmunol.2300841.